Drug kills cancer cells by restoring faulty tumor suppressor
(Press-News.org) A new study describes a compound that selectively kills cancer cells by restoring the structure and function of one of the most commonly mutated proteins in human cancer, the "tumor suppressor" p53. The research, published by Cell Press in the May 15th issue of the journal Cancer Cell, uses a novel, computer based strategy to identify potential anti-cancer drugs, including one that targets the third most common p53 mutation in human cancer, p53-R175H. The number of new cancer patients harboring this mutation in the United States who would potentially benefit from this drug is estimated to be 30,000 annually.
P53 recognizes cellular stress and either puts the brakes on cell proliferation, or kills the cell if the damage is irreparable. The gene encoding p53 is mutated in over half of human cancers, and loss of p53 function has been linked to many aspects of cancer including aggressiveness, metastasis and poor response to chemotherapy and radiation. "Restoring the function of mutant p53 with a drug has long been recognized as an attractive cancer therapeutic strategy," explains senior study author, Dr. Darren R. Carpizo, from The Cancer Institute of New Jersey. "However, it has proven difficult to find compounds that restore the lost function of a defective tumor-suppressor."
Dr. Alexei Vazquez, a co-author of the study, developed a computer based screening method to identify compounds that target tumor cells with p53 mutations, but not cells with normal p53. The screening method was unique because it involved cancer cells with diverse genetic backgrounds, a model that recapitulates what is seen in actual human cancers. This method identified several compounds that killed cancer cells containing mutant p53. One of the compounds did so by restoring the structure and function of the p53-R175H mutant. The researchers went on describe the details of the reactivation mechanism and showed that normal cells were not impacted by the compound.
In addition to identifying a compound for selectively restoring the function of the p53-R175H mutant, the findings also support the development of rationally targeted cancer therapies. "Anti-cancer drug development is moving in the direction of "personalized medicine" in which the drugs are chosen based on the molecular pathways that are deranged in an individual patient's tumor," concludes Dr. Carpizo. "Our findings support the growing trend in developmental therapeutics in which the efficacy of future cancer drugs will depend upon the knowledge of the patient's tumor genotype."
Yu et al.: "Allele Specific p53 Mutant Reactivation."
ELSE PRESS RELEASES FROM THIS DATE:
Asymptomatic patients who undergo treadmill exercise echocardiography (ExE) after coronary revascularization may be identified as being at high risk but those patients do not appear to have more favorable outcomes with repeated revascularization, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. The article is part of the journal's Less is More series.
Cardiac events and recurrent ischemia (a temporary shortage of oxygen caused by impaired blood flow; identified in the study as new or worsening cardiac wall motion ...
According to a small clinical trial reported by investigators from Japan, acupuncture appears to be associated with improvement of dyspnea (labored breathing) on exertion, in patients with chronic obstructive pulmonary disease (COPD), according to a study published Online First by Archives of Internal Medicine, a JAMA Network publication.
The management of dyspnea is an important target in the treatment of COPD, a common respiratory disease characterized by irreversible airflow limitation. COPD is predicted to be the third leading cause of death worldwide by 2020, according ...
Among African Americans with type 1 diabetes mellitus, narrower central retinal arteriolar equivalent (average diameter of the small arteries in the retina) is associated with an increased risk of six-year incidence of any cardiovascular disease and lower extremity arterial disease, according to a report in the May issue of Archives of Ophthalmology, a JAMA Network publication.
"Retinal arteriolar narrowing has long been described as one of the characteristic changes associated with hypertension and cardiovascular disease (CVD)," the authors write as background information ...
PITTSBURGH, May 14 - A small, external bioreactor holding human cells pumped out an anti-inflammatory protein to prevent organ damage and other complications in a rat with acute inflammation caused by bacterial products in a model of sepsis, according to a report from researchers at the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine. The findings were published today in the inaugural issue of Disruptive Science and Technology.
Inflammation is a necessary biological response that brings cells and proteins to the site of ...
Major depressive episodes can be prevented, and to help ensure that they are, the health care system should provide routine access to depression-prevention interventions, just as patients receive standard vaccines, according to a new article co-authored by UCSF researcher Ricardo F. Muñoz, PhD.
The article builds on a 2009 Institute of Medicine report on prevention of mental, emotional and behavioral disorders, which provided presented evidence that mental disorders can be prevented.
The article, "Major Depression Can Be Prevented," will appear in a special section ...
DETROIT – Henry Ford Hospital researchers have found that the presence of excess protein in a common urine test is an effective prognostic marker of acute renal failure in patients with severe sepsis.
Researchers analyzed data from 328 sepsis patients with no previous history of protein in the urine and found the urine dipstick test predicted the presence of renal failure in 55 percent of these patients.
A urine dipstick test is routinely done as part of a urinalysis to help diagnose urinary tract infections, kidney disease, diabetes and sepsis, the deadly bloodstream ...
Researchers at the University of Leeds have found a previously unknown mechanism through which pain is signalled by nerve cells – a discovery that could explain the current failings in the drug development process for painkillers and which may offer opportunities for a new approach.
The team, led by Dr Nikita Gamper of the University's Faculty of Biological Sciences, is investigating the difference between persistent pain, such as toothache, and pain that results from the increased sensitivity of nerves in injured or diseased tissue (for example when we touch inflamed ...
Scientists at A*STAR's Institute of Medical Biology (IMB), in collaboration with doctors and scientists in Jordan, Turkey, Switzerland and USA, have identified the genetic cause of a birth defect known as Hamamy syndrome . Their groundbreaking findings were published on May 13th in the prestigious journal Nature Genetics. The work lends new insights into common ailments such as heart disease, osteoporosis, blood disorders and possibly sterility.
Hamamy syndrome is a rare genetic disorder which is marked by abnormal facial features and defects in the heart, bone, blood ...
Research shows that street furniture, barriers, parks, public spaces and neighbourhood architecture can stir up powerful emotions in local residents. This should be taken into account in programmes designed to reduce tensions and foster community cohesion.
Four cities - Amsterdam, Beirut, Belfast and Berlin were chosen as the location of the research as each has a different social history and underlying tensions. The project was undertaken by Dr Ralf Brand of the University of Manchester and was funded by the Economic and Social Research Council (ESRC).
Dr Brand found ...
This is one of the principle conclusions of a study that has been published in the scientific journal Current Biology. Participants in the study included Evan Balaban (McGill University, Montreal), Manuel Desco (Gregorio Marañón General University Hospital of Madrid and UC3M) and Juan José Vaquero (UC3M). The researchers managed to arouse a chicken embryo by exposing it to a sound that would have meaning after its birth (for example, the sound of a chicken warning others of danger). However, their study has demonstrated that the animal does not have the same reaction when ...
LAST 30 PRESS RELEASES: